China expands drug bulk-buy program, puts pressure on pharma firms
BEIJING (Reuters) – China has expanded a pilot drug bulk-buying program to almost the entire country in an attempt to negotiate lower prices from drug manufacturers, heaping fresh pressure on multinational pharmaceutical companies and their domestic rivals. The program rolled out last year saw 11 Chinese cities, including Beijing and Shanghai, band together behind a… Read More »